RECOMBINATE 1000 IU

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Pieejams no:

TEVA MEDICAL MARKETING LTD.

ATĶ kods:

B02BD02

Zāļu forma:

POWDER FOR SOLUTION FOR INJECTION

Ievadīšanas:

I.V

Ražojis:

BAXTER S.A., BELGIUM

Ārstniecības grupa:

COAGULATION FACTOR VIII

Ārstēšanas norādes:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Autorizācija datums:

2010-07-01